BridgeBio Pharma (BBIO) had the highest return on March 10 by a large-cap US stock, returning 12.4%.

ASSET	DATE	% RETURN
BridgeBio Pharma (BBIO)	3/10/2026	12.4%
Wipro Limited ADR (WIT)	3/10/2026	9.91%
DigitalOcean (DOCN)	3/10/2026	7.62%
Caseys General Stores (CASY)	3/10/2026	5.98%
Circle Internet (CRCL)	3/10/2026	4.1%
Futu (FUTU)	3/10/2026	3.9%
Ciena (CIEN)	3/10/2026	3.8%
Millicom International Cellular (TIGO)	3/10/2026	3.73%
Nextpower (NXT)	3/10/2026	3.61%
Vertex Pharmaceuticals (VRTX)	3/10/2026	3.51%
Sandisk (SNDK)	3/10/2026	3.28%
Corning (GLW)	3/10/2026	3.18%
Globalstar, Inc Common Stock (GSAT)	3/10/2026	3.09%
Cameco (CCJ)	3/10/2026	3.07%
Regal Beloit (RRX)	3/10/2026	3.04%
Arm Holdings plc American Depositary Shares (ARM)	3/10/2026	3.03%
Intel (INTC)	3/10/2026	3.02%
Akamai Technologies (AKAM)	3/10/2026	2.9%
Summit Therapeutics (SMMT)	3/10/2026	2.9%
Dillard's (DDS)	3/10/2026	2.79%
Semtech (SMTC)	3/10/2026	2.71%
Banco Bradesco S/A ADR (BBDO)	3/10/2026	2.69%
Hesai Group Sponsored ADR (HSAI)	3/10/2026	2.69%
Grupo Cibest (CIB)	3/10/2026	2.68%
Brookfield Wealth Solutions (BNT)	3/10/2026	2.65%

Large-cap stocks are treated as having a market cap of $10B+.